Product Information
CARBAMAZEPINE 100 MG/5 ML SUSP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0925 per ML under NDC 51672404704. Its NADAC has been published 49 times since Oct 29, 2025.
FDA first approved this application on Sep 20, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/5mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672404704
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076729FDA Approved
9/20/2004
TE Code
AB
On Market Since
9/20/2004
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has been published 49 times since Oct 29, 2025, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0925 per ML |
|---|---|
| All-time high | $0.1134 (Dec 10, 2025) |
| All-time low | $0.0925 (Sep 23, 2026) |
| 52-week high | $0.1134 |
| 52-week low | $0.0925 |
| Median price | $0.1039 |
| Average price | $0.1034 |
| Largest weekly change | -4.7% (Feb 18, 2026) |
| Weeks tracked | 49 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carbamazepine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mood Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 100 MG/5 ML SUSP, manufactured by Sun Pharmaceutical Industries Inc., is $0.0925 per ML (NDC 51672404704), effective Sep 30, 2026.
How has the price of CARBAMAZEPINE 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has declined 17.2%. It has been tracked across 49 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 100 MG/5 ML SUSP?
Since Oct 29, 2025, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has ranged from a low of $0.0925 (Sep 23, 2026) to a high of $0.1134 (Dec 10, 2025), with a median of $0.1039 per ML.
Are there cheaper alternatives to CARBAMAZEPINE 100 MG/5 ML SUSP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBAMAZEPINE 100 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBAMAZEPINE 100 MG/5 ML SUSP?
CARBAMAZEPINE 100 MG/5 ML SUSP (NDC 51672404704) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.